TLR9 and neoplasm: CpG oligodeoxynucleotide (CpG ODN) is a commonly used immune adjuvant that can effectively trigger a mammalian immune response through toll-like receptor 9 (TLR9) signaling and has been used as an immune adjuvant against infection and tumor[63-70].